Pathogenic variants in <i>BRAT1</i> are associated with a spectrum of clinical syndromes ranging from Lethal Neonatal Rigidity and Multifocal Seizure syndrome (RMFSL) to Neurodevelopmental Disorder with Cerebellar Atrophy and with or without Seizures (NEDCAS). This evidence concerns the gene BRAT1 and Rigidity.